MiNK Therapeutics, Inc. (INKT) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of MiNK Therapeutics, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INKT
MiNK Therapeutics, Inc.
$12.15HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT
KLRS
Kalaris Therapeutics Inc
$2.90HealthcareDelayed quote: Oct 6, 2026, 10:47 AM EDT
Total return — INKT vs KLRS
growth of $100 · dividends reinvested · last 5yINKT -89.8% (-36.7%/yr)KLRS -100.0% (-81.1%/yr)INKT compounded faster over this window
Log scale — wide-divergence pair
INKT KLRS
INKT vs KLRS: by the numbers
- •KLRS is the larger company ($63M vs $61M market cap).
Metrics side by side
Valuation
| Metric | INKT | KLRS |
|---|---|---|
| P/B ratio | N/A | 1.10 |
Profitability
| Metric | INKT | KLRS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -76.75% |
| ROIC | -604.20% | -52.40% |
Growth (annualized)
| Metric | INKT | KLRS |
|---|---|---|
| Total return CAGR (5Y) | N/A | -81.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.